Pregnancy and acromegaly: A review

Pituitary

Volumn 15, Issue 1, 2012, Pages 59-63

  Cheng, Vicky ^a   Faiman, Charles ^a   Kennedy, Laurence ^a   Khoury, Fadi ^a   Hatipoglu, Betul ^a   Weil, Robert ^a   Hamrahian, Amir ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acromegaly; Medical therapy; Pregnancy; Surgery

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; QUINAGOLIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ACROMEGALY; BINDING AFFINITY; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; GROWTH HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HYPERPROLACTINEMIA; NAUSEA; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; ORGAN SIZE; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT DURATION; UPREGULATION;

ACROMEGALY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84858160589     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0330-3     Document Type: Review

References (37)

1. Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83:727-731 (Pubitemid 28496436)
2. Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95:4518-4525
3. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G (1988) The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66:1171-1180
4. Beckers A, Stevenaert A, Foidart JM, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71:725-731
5. Lau SL, McGrath S, Evain-Brion D, Smith R (2008) Clinical and biochemical improvement in acromegaly during pregnancy. J Endocrinol Invest 31:255-261 (Pubitemid 351638406)
6. Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82:2777-2781
7. Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155:279-284 (Pubitemid 44269444)
8. Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25:693-721 (Pubitemid 39366048)
9. Molitch ME (2006) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 35:99-116
10. Yap AS, Clouston WM, Mortimer RH, Drake RF (1990) Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy. Am J Obstet Gynecol 163:477-478 (Pubitemid 20287611)
11. Hisano M, Sakata M, Watanabe N, Kitagawa M, Murashima A, Yamaguchi K (2006) An acromegalic woman first diagnosed in pregnancy. Arch Gynecol Obstet 274:171-173 (Pubitemid 43781426)
12. Takeuchi K, Funakoshi T, Oomori S, Maruo T (1999) Successful pregnancy in an acromegalic women treated with octreotide. Obstet Gynecol 93:848 (Pubitemid 29197923)
13. Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihira T, Eto S (1997) A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44:117-120 (Pubitemid 27150169)
14. McIntyre HD, Russell A, Serek R, Veveris-Lowe T, Cotterill A, Cowley D, Barnard R (2002) Placental growth hormone is not suppressed by oral glucose loading in normal human pregnancy. Horm Metab Res 34:250-253 (Pubitemid 34666588)
15. Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95:4680-4687
16. Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114:135-139
17. Kupersmith MJ, Rosenberg C, Kleinberg D (1994) Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121: 473-477
18. Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG (1990) Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine. J Endocrinol Invest 13:193 (Pubitemid 20111837)
19. Lunardi P, Rizzo A, Missori P, Fraioli B (1991) Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transphenoidal approach. Int J Gynaecol Obstet 34:71-74 (Pubitemid 20378392)
20. Guven S, Durukan T, Berker M, Basaran A, Saygan-Karamursel B, Palaoglu S (2006) A case of acromegaly in pregnancy: concomitant transsphenoidal adenomectomy and cesarean section. J Matern Fetal Neonatal Med 19:69-71
21. Mozas J, Ocon E, de la Lopez Torre M, Suarez AM, Miranda JA, Herruzo AJ (1999) Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. Int J Gynaecol Obstet 65:71-73 (Pubitemid 29227381)
22. Verhaeghe J (2008) Does the physiological acromegaly of pregnancy benefit the fetus? Gynecol Obstet Invest 66:217-226
23. Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ercole AJ, Underwood LE (1990) Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127:1278-1286 (Pubitemid 20277611)
24. Krupp P, Monka C (1987) Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 65:823-827 (Pubitemid 17123339)
25. Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR treatment throughout pregnancy in an acrome-galic woman. Clin Endocrinol (Oxf) 55:411-415 (Pubitemid 32823052)
26. Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. Clin Endocrinol (Oxf) 72:668-677
27. Neal JM (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract 6:148-150
28. Mikhail N (2002) Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc 77:297-298
29. Caron P, Gerbeau C, Pradayrol L (1995) Maternal-fetal transfer of octreotide. N Engl J Med 333:601-602
30. Caron P, Buscail L, Beckers A, Esteve JP, Igout A, Hennen G, Susini C (1997) Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 82:3771-3776 (Pubitemid 27509370)
31. de Menis E, Billeci D, Marton E, Gussoni G (1999) Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. J Clin Endocrinol Metab 84:1489 (Pubitemid 30644425)
32. van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358:1754-1759 (Pubitemid 33152999)
33. Qureshi A, Kalu E, Ramanathan G, Bano G, Croucher C, Panahloo A (2006) IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. J Assist Reprod Genet 23:439-442 (Pubitemid 46020547)
34. Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92:3374-3377 (Pubitemid 47435307)
35. Landolt AM, Schmid J, Wimpfheimer C, Karlsson ER, Boerlin V (1989) Successful pregnancy in a previously infertile woman treated with SMS-201-995 for acromegaly. N Engl J Med 320:671-672 (Pubitemid 19072480)
36. Hierl T, Ziegler R, Kasperk C (2000) Pregnancy in persistent acromegaly. Clin Endocrinol (Oxf) 53:262-263 (Pubitemid 30643462)
37. Takano T, Saito J, Soyama A, Ito H, Iizuka T, Yoshida T, Nishikawa T (2006) Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocr J 53:209-212